Cargando…

First-line Helicobacter pylori eradication rates are significantly lower in patients with than those without type 2 diabetes mellitus

Purpose: To assess the difference of the first-line therapy for Helicobacter pylori in patients with or without type 2 diabetes (DM) and to investigate the clinical factors influencing treatment outcomes. Patients and methods: In total, 719 patients with H. pylori infection were treated with 7-day s...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Chih-Chien, Kuo, Chung-Mou, Hsu, Chien-Ning, Yang, Shih-Cheng, Wu, Cheng-Kun, Tai, Wei-Chen, Liang, Chih-Ming, Wu, Keng-Liang, Huang, Chih-Fang, Bi, Kuo-Wei, Lee, Chen-Hsiang, Chuah, Seng-Kee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554512/ https://www.ncbi.nlm.nih.gov/pubmed/31239721 http://dx.doi.org/10.2147/IDR.S194584

Ejemplares similares

First-Line Helicobacter pylori Eradication in Patients with Chronic Kidney Diseases in Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Quinolone-Containing Therapies in the Eradication of Helicobacter pylori
por: Chuah, Seng-Kee, et al.
Publicado: (2014)

Efficacy of a 14-day quadruple-therapy regimen for third-line Helicobacter pylori eradication
por: Huang, Hsiang Tso, et al.
Publicado: (2018)

Eradication Rates for Esomeprazole and Lansoprazole-Based 7-Day Non-Bismuth Concomitant Quadruple Therapy for First-Line Anti-Helicobacter pylori Treatment in Real World Clinical Practice
por: Hung, Kuo-Tung, et al.
Publicado: (2021)

The Clinical and Bacteriological Factors for Optimal Levofloxacin-Containing Triple Therapy in Second-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2014)

A comparison between dexlansoprazole modified release–based and lansoprazole-based nonbismuth quadruple (concomitant) therapy for first-line Helicobacter pylori eradication: a prospective randomized trial
por: Tai, Wei-Chen, et al.
Publicado: (2019)

Association between Helicobacter pylori eradication and the risk of coronary heart diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2018)

The efficacies of non-bismuth containing quadruple therapies in the treatment of first-line anti-Helicobacter pylori across 4-year time interval with changing antibiotics resistance
por: Huang, Tzu-Hsin, et al.
Publicado: (2021)

A Randomized Control Trial Comparing 2 Levofloxacin-Containing Second-Line Therapies for Helicobacter pylori Eradication
por: Chuah, Seng-Kee, et al.
Publicado: (2016)

The Association of Helicobacter pylori Eradication with the Occurrences of Chronic Kidney Diseases in Patients with Peptic Ulcer Diseases
por: Wang, Jiunn-Wei, et al.
Publicado: (2016)

Seven-Day Nonbismuth Containing Quadruple Therapy Could Achieve a Grade “A” Success Rate for First-Line Helicobacter pylori Eradication
por: Tai, Wei-Chen, et al.
Publicado: (2015)

Ten-Day versus 14-Day Levofloxacin-Containing Triple Therapy for Second-Line Anti-Helicobacter pylori Eradication in Taiwan
por: Tai, Wei-Chen, et al.
Publicado: (2013)

The Efficacy and Safety of 14-day Rabeprazole Plus Amoxicillin High Dose Dual Therapy by Comparing to 14-day Rabeprazole-Containing Hybrid Therapy for the Naïve Helicobacter pylori Infection in Taiwan: A Randomized Controlled Trial
por: Tai, Wei-Chen, et al.
Publicado: (2023)

Update on the second-line treatment of Helicobacter pylori infection: a narrative review
por: Shih, Chih-An, et al.
Publicado: (2023)

A community-based study on the association between Helicobacter pylori Infection and obesity
por: Chen, Li-Wei, et al.
Publicado: (2018)

Trend of changes in antibiotic resistance in Helicobacter pylori from 2013 to 2019: a multicentre report from Taiwan
por: Liang, Chih-Ming, et al.
Publicado: (2020)

The impact of aspirin on Klebsiella pneumoniae liver abscess in diabetic patients
por: Tai, Chien-Hsiang, et al.
Publicado: (2020)

The Effect of Helicobacter pylori Eradication on the Levels of Essential Trace Elements
por: Wu, Meng-Chieh, et al.
Publicado: (2014)

The Clinical Correlations of Helicobacter pylori Virulence Factors and Chronic Spontaneous Urticaria
por: Chiu, Yi-Chun, et al.
Publicado: (2013)

Predicting risk factors for rebleeding, infections, mortality following peptic ulcer bleeding in patients with cirrhosis and the impact of antibiotics prophylaxis at different clinical stages of the disease
por: Kuo, Ming-Te, et al.
Publicado: (2015)

The efficacy of limited endoscopic sphincterotomy plus endoscopic papillary large balloon dilation for removal of large bile duct stones
por: Kuo, Chung-Mou, et al.
Publicado: (2019)

First-week clinical responses to dexlansoprazole 60 mg and esomeprazole 40 mg for the treatment of grades A and B gastroesophageal reflux disease
por: Liang, Chih-Ming, et al.
Publicado: (2017)

Catechins and Sialic Acid Attenuate Helicobacter pylori-Triggered Epithelial Caspase-1 Activity and Eradicate Helicobacter pylori Infection
por: Yang, Jyh-Chin, et al.
Publicado: (2013)

The Associations Between Helicobacter pylori Infection, Serum Vitamin D, and Metabolic Syndrome: A Community-Based Study
por: Chen, Li-Wei, et al.
Publicado: (2016)

Clinical efficacy of 60-mg dexlansoprazole and 40-mg esomeprazole after 24 weeks for the on-demand treatment of gastroesophageal reflux disease grades A and B: a prospective randomized trial
por: Chiang, Hung-Hsien, et al.
Publicado: (2019)

Endoscopic Management of Foreign Bodies in the Upper Gastrointestinal Tract of Adults
por: Yao, Chih-Chien, et al.
Publicado: (2015)

Helicobacter pylori Infection Increases Insulin Resistance and Metabolic Syndrome in Residents Younger than 50 Years Old: A Community-Based Study
por: Chen, Li-Wei, et al.
Publicado: (2015)

Relationship between Helicobacter pylori infection and bone mineral density: a retrospective cross-sectional study
por: Pan, Bo-Lin, et al.
Publicado: (2018)

Comparison between Single-Dose Esomeprazole- and Pantoprazole-Based Triple Therapy on the Effectiveness for Helicobacter pylori Eradication in Taiwanese Population
por: Shih, Hsiang-Yao, et al.
Publicado: (2012)

The Application of High-Dose Proton Pump Inhibitor Induction Treatment before Dual Therapy for Helicobacter pylori Eradication: An Open-Label Random Trial
por: Chen, Li-Wei, et al.
Publicado: (2021)

Increased Risk of Pyogenic Liver Abscess after Endoscopic Sphincterotomy for Treatment of Choledocholithiasis
por: Wu, Cheng-Kun, et al.
Publicado: (2021)

Analysis of Patients with Helicobacter pylori Infection and the Subsequent Risk of Developing Osteoporosis after Eradication Therapy: A Nationwide Population-Based Cohort Study
por: Shih, Hong-Mo, et al.
Publicado: (2016)

Risk factors influencing the outcome of peptic ulcer bleeding in chronic kidney disease after initial endoscopic hemostasis: A nationwide cohort study
por: Liang, Chih-Ming, et al.
Publicado: (2016)

Risk of Rebleeding and Mortality in Cirrhotic Patients with Peptic Ulcer Bleeding: A 12-Year Nationwide Cohort Study
por: Yang, Shih-Cheng, et al.
Publicado: (2017)

The Role of Adjuvant Acid Suppression on the Outcomes of Bleeding Esophageal Varices after Endoscopic Variceal Ligation
por: Wu, Cheng-Kun, et al.
Publicado: (2017)

Limited precut sphincterotomy combined with endoscopic papillary balloon dilation for common bile duct stone removal in patients with difficult biliary cannulation
por: Kuo, Chung-Mou, et al.
Publicado: (2016)

Medical expenses in treating acute esophageal variceal bleeding: A 15-year nationwide population-based cohort study
por: Liu, Chueh-Ling, et al.
Publicado: (2016)

Risk of subsequent prostate cancer in peptic ulcer patients who received helicobacter pylori eradication therapy: an Asian population-based cohort study
por: Fang, Chu-Wen, et al.
Publicado: (2020)

Correlation between Psychosomatic Assessment, Heart Rate Variability, and Refractory GERD: A Prospective Study in Patients with Acid Reflux Esophagitis
por: Wang, Hsin-Ming, et al.
Publicado: (2023)

Current status of Helicobacter pylori eradication and risk factors for eradication failure
por: Yan, Tian-Lian, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_puem1q4qnpeo7vf7k53j7k719q